Thalidomide Prevents the Progression of Peritoneal Fibrosis in Mice

Thalidomide is clinically recognized as a therapeutic agent for multiple myeloma and has been known to exert anti-angiogenic actions. Recent studies have suggested the involvement of angiogenesis in the progression of peritoneal fibrosis. The present study investigated the effects of thalidomide on...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hideyuki, Furusu, Akira, Nishino, Tomoya, Obata, Yoko, Nakazawa, Yuka, Nakazawa, Masayuki, Hirose, Misaki, Abe, Katsushige, Koji, Takehiko, Kohno, Shigeru
Formato: Texto
Lenguaje:English
Publicado: Japan Society of Histochemistry and Cytochemistry 2011
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096082/
https://www.ncbi.nlm.nih.gov/pubmed/21614166
http://dx.doi.org/10.1267/ahc.10030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096082/
https://www.ncbi.nlm.nih.gov/pubmed/21614166
http://dx.doi.org/10.1267/ahc.10030

Ejemplares similares